Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study.
Shields BM. et al, (2022), Nat Med
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes - Authors' reply.
Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol, 10, 841 - 842